Bristol-Myers Squibb Company
PYRROLIDINE GPR40 MODULATORS

Last updated:

Abstract:

The present invention provides compounds of Formula (I): ##STR00001## or a stereoisomer, a tautomer, a pharmaceutically acceptable salt, a polymorph, or a solvate thereof, wherein all of the variables are as defined herein. These compounds are GPR40 G protein-coupled receptor modulators which may be used as medicaments.

Status:
Application
Type:

Utility

Filling date:

8 Jun 2020

Issue date:

24 Sep 2020